DJIA 18,132.70 -81.72 -0.45%
NASDAQ 4,963.53 -24.36 -0.49%
S&P 500 2,104.50 -6.24 -0.30%
market minute promo

Biogen Idec (NASDAQ: BIIB)

company name or ticker
Company Photos
(Click to zoom)

iShares S&P 500 Growth ETF Experiences Big Outflow

Biotech Stock Mailbag: Receptos, Celldex Therapeutics, Exact Sciences

Short Sellers Increase Bets Against Biotech as Shares Continue to Rise

5 Things Biogen Idec Inc's Management Wants You to Know

Pipeline data, new drug launches, and sales of established drugs top the list.

The Catalysts Biogen Idec Investors Should Watch

3 Stocks Dragging The Drugs Industry Downward

The Most Dominant Stocks in 2015 Taking Nasdaq to 5,000 and Beyond

Evercore ISI Technical Analysis: The 'Single Best Idea'

3 Biotech Stocks I'd Love to Stash Away in My Portfolio Forever

Celgene Corporation, Gilead Sciences, and Biogen Idec are three names that I want to own for the long haul.

Seeking Alpha's Biotech Weekly: Sanofi's New Chief, Sarissa Shakes Ariad, And More

See More Articles...